Cargando…

Multilayer Spheroids To Quantify Drug Uptake and Diffusion in 3D

[Image: see text] There is a need for new quantitative in vitro models of drug uptake and diffusion to help assess drug toxicity/efficacy as well as new more predictive models for drug discovery. We report a three-dimensional (3D) multilayer spheroid model and a new algorithm to quantitatively study...

Descripción completa

Detalles Bibliográficos
Autores principales: Achilli, Toni-Marie, McCalla, Stephanie, Meyer, Julia, Tripathi, Anubhav, Morgan, Jeffrey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096226/
https://www.ncbi.nlm.nih.gov/pubmed/24641346
http://dx.doi.org/10.1021/mp500002y
_version_ 1782326125674889216
author Achilli, Toni-Marie
McCalla, Stephanie
Meyer, Julia
Tripathi, Anubhav
Morgan, Jeffrey R.
author_facet Achilli, Toni-Marie
McCalla, Stephanie
Meyer, Julia
Tripathi, Anubhav
Morgan, Jeffrey R.
author_sort Achilli, Toni-Marie
collection PubMed
description [Image: see text] There is a need for new quantitative in vitro models of drug uptake and diffusion to help assess drug toxicity/efficacy as well as new more predictive models for drug discovery. We report a three-dimensional (3D) multilayer spheroid model and a new algorithm to quantitatively study uptake and inward diffusion of fluorescent calcein via gap junction intercellular communication (GJIC). When incubated with calcein-AM, a substrate of the efflux transporter P-glycoprotein (Pgp), spheroids from a variety of cell types accumulated calcein over time. Accumulation decreased in spheroids overexpressing Pgp (HEK-MDR) and was increased in the presence of Pgp inhibitors (verapamil, loperamide, cyclosporin A). Inward diffusion of calcein was negligible in spheroids that lacked GJIC (OVCAR-3, SK-OV-3) and was reduced in the presence of an inhibitor of GJIC (carbenoxolone). In addition to inhibiting Pgp, verapamil and loperamide, but not cyclosporin A, inhibited inward diffusion of calcein, suggesting that they also inhibit GJIC. The dose response curves of verapamil’s inhibition of Pgp and GJIC were similar (IC(50): 8 μM). The method is amenable to many different cell types and may serve as a quantitative 3D model that more accurately replicates in vivo barriers to drug uptake and diffusion.
format Online
Article
Text
id pubmed-4096226
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-40962262015-03-18 Multilayer Spheroids To Quantify Drug Uptake and Diffusion in 3D Achilli, Toni-Marie McCalla, Stephanie Meyer, Julia Tripathi, Anubhav Morgan, Jeffrey R. Mol Pharm [Image: see text] There is a need for new quantitative in vitro models of drug uptake and diffusion to help assess drug toxicity/efficacy as well as new more predictive models for drug discovery. We report a three-dimensional (3D) multilayer spheroid model and a new algorithm to quantitatively study uptake and inward diffusion of fluorescent calcein via gap junction intercellular communication (GJIC). When incubated with calcein-AM, a substrate of the efflux transporter P-glycoprotein (Pgp), spheroids from a variety of cell types accumulated calcein over time. Accumulation decreased in spheroids overexpressing Pgp (HEK-MDR) and was increased in the presence of Pgp inhibitors (verapamil, loperamide, cyclosporin A). Inward diffusion of calcein was negligible in spheroids that lacked GJIC (OVCAR-3, SK-OV-3) and was reduced in the presence of an inhibitor of GJIC (carbenoxolone). In addition to inhibiting Pgp, verapamil and loperamide, but not cyclosporin A, inhibited inward diffusion of calcein, suggesting that they also inhibit GJIC. The dose response curves of verapamil’s inhibition of Pgp and GJIC were similar (IC(50): 8 μM). The method is amenable to many different cell types and may serve as a quantitative 3D model that more accurately replicates in vivo barriers to drug uptake and diffusion. American Chemical Society 2014-03-18 2014-07-07 /pmc/articles/PMC4096226/ /pubmed/24641346 http://dx.doi.org/10.1021/mp500002y Text en Copyright © 2014 American Chemical Society Terms of Use (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html)
spellingShingle Achilli, Toni-Marie
McCalla, Stephanie
Meyer, Julia
Tripathi, Anubhav
Morgan, Jeffrey R.
Multilayer Spheroids To Quantify Drug Uptake and Diffusion in 3D
title Multilayer Spheroids To Quantify Drug Uptake and Diffusion in 3D
title_full Multilayer Spheroids To Quantify Drug Uptake and Diffusion in 3D
title_fullStr Multilayer Spheroids To Quantify Drug Uptake and Diffusion in 3D
title_full_unstemmed Multilayer Spheroids To Quantify Drug Uptake and Diffusion in 3D
title_short Multilayer Spheroids To Quantify Drug Uptake and Diffusion in 3D
title_sort multilayer spheroids to quantify drug uptake and diffusion in 3d
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096226/
https://www.ncbi.nlm.nih.gov/pubmed/24641346
http://dx.doi.org/10.1021/mp500002y
work_keys_str_mv AT achillitonimarie multilayerspheroidstoquantifydruguptakeanddiffusionin3d
AT mccallastephanie multilayerspheroidstoquantifydruguptakeanddiffusionin3d
AT meyerjulia multilayerspheroidstoquantifydruguptakeanddiffusionin3d
AT tripathianubhav multilayerspheroidstoquantifydruguptakeanddiffusionin3d
AT morganjeffreyr multilayerspheroidstoquantifydruguptakeanddiffusionin3d